International Pancreatic Surgery Outcomes Study - PancreasGroup.Org

Study Overview
=================
Brief Summary
-----------------
Snapshot study worldwide over 3 months in 2021. Provide a verified record of true morbidity and mortality. Identify modifiable predicting factors of outcome. Obtain PubMed citable co-authorship,

Detailed Description
-----------------
The PancreasGroup.org team is conducting a snapshot clinical study investigating the outcomes of pancreatic surgery worldwide. This collaborative model for snapshot clinical studies is a well-established approach for assessing current practice in a short period of time. There will be 3 months of prospective enrolment and 3 months follow up within a 12-month frame. The study will provide highly valuable data on outcomes after pancreatic surgery. The investigators are aiming at providing a verified record of true morbidity and mortality in consecutive unselected patients. This way the investigators will help identify relevant, modifiable predicting factors for outcome after pancreatic surgery.

Official Title
-----------------
PancreasGroup.Org - International Pancreatic Surgery Outcomes Study

Conditions
-----------------
Pancreatic Neoplasms, Pancreatitis

Intervention / Treatment
-----------------
* Procedure: Pancreatic surgery


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All indications (including benign and malignant) Open, laparoscopic or robotic. Elective or emergency. Partial or total pancreatectomies. Pancreatic tumour enucleations. Procedures with concomitant vascular or other organ resections. Pancreatic duct drainage procedures (e.g. Frey, Puestow, or Beger) Adults 18 years of age or older. Exclusion Criteria: Pancreas or islet cell transplantation. Transcutaneous or transgastric imaging-guided ablation (e.g. RFA) or electroporation (e.g. NanoKnife). Endoscopic (e.g. endoscopic retrograde cholangiopancreatography, stent or lithotripsy) procedures. Endoscopic transgastric and surgical necrosectomies excluded. Patients less than 18 years of age excluded.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients undergoing pancreatic surgery<br>Patients undergoing any type of pancreatic surgery. | Procedure: Pancreatic surgery<br>* Open, laparoscopic or robotic surgery of the pancreas<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mortality | Postoperative death | 90 days postoperatively | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Morbidity | Postoperative complication rates classified according to Clavien-Dindo | 90 days postoperatively | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
pancreatic surgery, snapshot, global surgery, predictors, outcomes